Acute Complications Remain a Serious Risk for People With Type 1 Diabetes in Japan

Researchers in Japan conducted the first nationwide study examining how often acute diabetic complications occur in people with Type 1 diabetes. Using data from 125 medical institutions across the country, they analyzed information from 2,679 patients with confirmed Type 1 diabetes diagnoses. The goal was to understand how common these dangerous complications are and what factors increase the risk.

Despite receiving insulin therapy, a substantial portion of study participants experienced life-threatening acute complications. The findings were striking: 18.8% of patients experienced diabetic ketosis (buildup of ketones in the blood), while 7.8% experienced the more severe diabetic ketoacidosis. Additionally, 12.7% experienced at least one episode of severe hypoglycemia (dangerously low blood sugar), and 28.9% reported hypoglycemic unawareness—a condition where people lose the warning signs that their blood sugar is dropping too low.

Researchers measured C-peptide levels in study participants. C-peptide is a marker of how much insulin the body is still producing on its own. People who experienced acute complications had significantly lower C-peptide levels than those who did not, suggesting that reduced remaining insulin production is linked to higher risk of these dangerous events.

Type 1 diabetes develops in different ways—some people experience rapid onset, while others develop the condition more slowly. The study found that acute complications occurred at similar rates across different Type 1 diabetes subtypes, including slowly progressive forms. This suggests that the risk of these complications is not limited to any single presentation of the disease.

Even as insulin therapy has advanced, acute diabetic complications remain a significant health concern in Japan's Type 1 diabetes population. The researchers conclude that improved medical care and management strategies are needed to reduce the burden of these life-threatening events. Understanding how often these complications occur and which patients are at highest risk is an important step toward better prevention and treatment.

Source: Journal of diabetes investigation. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.